Natural Health Trends (NHTC) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
29 Jul, 2026Executive summary
Q2 2026 net sales were $7.6 million, a 23% year-over-year decline, mainly due to cautious consumer spending and regulatory uncertainty in China and Hong Kong, with Hong Kong (mainly sales to China) accounting for 83% of revenue.
Gross profit margin improved to 75.2% from 73.9% year-over-year, attributed to shifting manufacturing to East Asia to reduce tariff exposure and logistics costs.
Operating loss was $643,000 in Q2 2026, compared to $333,000 in Q2 2025; net loss was $451,000 or $0.05 per diluted share, versus net income of $15,000 last year.
Restructuring initiatives led to $300,000 in quarterly cost savings and over $600,000 year-to-date, with further savings expected in the second half of 2026.
The board authorized resumption of share repurchases, with $15.9 million remaining under the program; $10.3 million was used for repurchases and dividends in the first half of 2026.
Financial highlights
Q2 2026 net sales were $7.6 million (down 23% YoY); H1 2026 net sales were $16.8 million (down 18% YoY).
Gross profit for Q2 2026 was $5.7 million (75.2% margin); H1 2026 gross profit was $12.6 million (75.1% margin).
Operating expenses for Q2 2026 were $6.4 million, down from $7.6 million in Q2 2025.
Net cash used in operating activities was $2.2 million for the first six months, down from $5.2 million in the prior year period.
Cash, cash equivalents, and marketable securities totaled $18.6 million at June 30, 2026, down from $28.9 million at year-end 2025.
Outlook and guidance
Management expects continued uncertainty in China due to regulatory changes and negative consumer sentiment, with further restructuring or compliance actions possible.
Additional cost savings from restructuring are expected in the second half of 2026.
Focus remains on financial discipline, innovation, digital enhancements, and global field engagement, with ongoing investment in China-based manufacturing and infrastructure.
25th anniversary celebration in Hong Kong planned for Q3 2026, expected to boost engagement.
Latest events from Natural Health Trends
- Revenue down 2% year-over-year, orders up 9%, $0.20 dividend declared, trade risks persist.NHTC
Q1 20258 Jul 2026 - Q1 2026 revenue dropped 14% year-over-year, with a net loss of $154,000 and 75% gross margin.NHTC
Q1 202629 Apr 2026 - Shareholders will vote on director elections, a new equity plan, and auditor ratification.NHTC
Proxy filing24 Mar 2026 - Director elections, equity plan, and auditor ratification up for vote at May 2026 meeting.NHTC
Proxy filing24 Mar 2026 - Annual meeting to elect directors, approve equity plan, and ratify auditor, with focus on governance.NHTC
Proxy filing24 Mar 2026 - Q4 revenue up 3% sequentially; $1.5M in annual savings and $0.10 dividend declared.NHTC
Q4 20254 Feb 2026 - Flat Q2 sales, improved profit, and Hong Kong's first sales growth since Q1 2023.NHTC
Q2 20242 Feb 2026 - Q3 2024 sales up 1% to $10.7M, net income $35K, and $0.20 dividend declared.NHTC
Q3 202417 Jan 2026 - Q4 2024 revenue flat, Greater China up 7%, net income $176K, $9.2M dividends paid.NHTC
Q4 202424 Dec 2025